Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/GlucoTrack, Inc./ 8-K

Current Report · Items 5.03, 8.01, 9.01 · 8-K

GlucoTrack, Inc.

GCTKNASDAQEQUITYCurrent

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other Events

Filed Aug 28, 2026Accepted Aug 28, 2026, 5:15 PM EDTCIK 1506983Accession 0001493152-26-040653
View company →Permanent SEC source ↗
Share

Company context

The Company was incorporated on May 18, 2010 under the laws of the State of Delaware. We are a medical device company focused on the development of an implantable continuous blood glucose monitor (“CBGM”) for persons with Type 1 diabetes and insulin-dependent Type 2 diabetes (the “Glucotrack CBGM”).

Current securities

GCTKNASDAQ · EQUITY · Current
Historical securities (1)
IGAPOTC · EQUITY · Historical · closed Mar 11, 2022

Recent company filings

  1. 424B5 filingSep 24, 2026
  2. Entry into a Material Definitive Agreement · Regulation FD DisclosureSep 24, 2026
  3. 425 filingSep 23, 2026
  4. Regulation FD DisclosureSep 23, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 18, 2026